CABG articles & resources on Made-in-China.com

DCRI Has Been Selected by Oxygen Biotherapeutics to Conduct The Phase III Clinical Trial

Dec 13, 2013

Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...

Tags: health, medicine

First Us Patient in Extravascular Nitinol Prosthesis Trial Is Treated by Kips Bay

Feb 7, 2013

Kips Bay Medical has treated the first US patient in a multi-center, randomized eMESH I clinical trial using its extravascular nitinol (nickel titanium alloy) prosthesis. The prosthesis, eSVS Mesh, is used as an external saphenous vein ...

Tags: Medical, Drug, extravascular nitinol prosthesis

Trial on Pericardium-Closing ECM Technology; Confirms Safe Use Is Completed by Cormatrix

Jan 24, 2013

US-based CorMatrix Cardiovascular has completed trial on its ECM technology that helps in closing the pericardium of patients undergoing postoperative coronary artery bypass grafting (CABG) and said the trial results confirm its safe use. ...

Tags: CorMatrix Cardiovascular, ECM technology, pericardium, CABG

Many of Those People Continue to Be Treated by Angioplasty

Jan 11, 2013

For almost two decades research has suggested that people with diabetes and multiple clogged arteries live longer and have fewer heart attacks if they undergo bypass surgery instead of angioplasty. Yet many of those people continue to be ...

Tags: diabetes, multiple clogged arteries, healthcare, heart attacks

Kips Bay Medical's eMESH I Clinical Feasibility Trial Moves Steps Further

Dec 17, 2012

American medical device firm Kips Bay Medical's eMESH I clinical feasibility trial has moved a step further, with first patient enrolling to the study at a European hospital. Switzerland-based Bern University Hospital has recently ...

Tags: eSVS Mesh, Kips Bay, CABG Surgery

CABG

DCRI Has Been Selected by Oxygen Biotherapeutics to Conduct The Phase III Clinical Trial

First Us Patient in Extravascular Nitinol Prosthesis Trial Is Treated by Kips Bay

Trial on Pericardium-Closing ECM Technology; Confirms Safe Use Is Completed by Cormatrix

Many of Those People Continue to Be Treated by Angioplasty

Kips Bay Medical's eMESH I Clinical Feasibility Trial Moves Steps Further

Related Products